Victory RS Investors C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Victory RS Investors Fund Class C RIVCX
- NAV / 1-Day Return 14.18 / +1.36 %
- Total Assets 70.9M
-
Adj. Expense Ratio
2.070%
- Expense Ratio 2.070%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Mid-Cap Blend
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.04%
- Turnover 93%
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 12:10 AM GMT+0
Morningstar’s Analysis RIVCX
Will RIVCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the RIVCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of RIVCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Globe Life Inc | 5.39 | 4M | Financial Services |
MarketAxess Holdings Inc | 5.24 | 4M | Financial Services |
Exxon Mobil Corp | 5.22 | 4M | Energy |
The St. Joe Co | 4.99 | 3M | Real Estate |
CVS Health Corp | 4.63 | 3M | Healthcare |
Plains GP Holdings LP Class A | 4.56 | 3M | Energy |
The Cigna Group | 4.15 | 3M | Healthcare |
Mattel Inc | 3.67 | 3M | Consumer Cyclical |
Union Pacific Corp | 3.50 | 2M | Industrials |
Teva Pharmaceutical Industries Ltd ADR | 3.49 | 2M | Healthcare |
United States